SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

APE fuels culture. Backed by the best club in the world and hundreds of thousands of holders worldwide, it’s the token for digital and IRL communities, builders, creators, collectors, gamers, and beyond.  APE is the native gas token of ApeChain and is available across multiple ecosystems including Ethereum, Arbitrum, Solana and HyperLiquid.z  ApeCoin's mission is is to supercharge its ecosystem by supporting high-quality builders &amp; reinforcing 3 core pillars: ApeChain, Bored Ape Yacht Club, and Otherside.

ApeCoin

ApeCoin is seeing heightened community engagement as speculators debate its potential for a sharp technical reversal, fueled by ongoing discussions regarding its utility, ecosystem developments like ApeChain, and speculative comparisons to past market cycles. While some traders are actively hunting for entry points amid high volatility, others remain cautious, debating whether recent price fluctuations represent a bottoming process or continued downward pressure.

MaxLinear, Inc. engages in the provision of communications systems-on-chip (SoC) solutions used in broadband, mobile and wireline infrastructure, data center, and industrial and multi-market applications. Its products include cable broadband modems and gateways, wireline connectivity devices, radio frequency transceivers, fiber-optic modules, video set-top boxes and gateways, hybrid analog and digital televisions, direct broadcast satellite outdoor and indoor units, and power management and interface products. The company was founded by Kimihiko Imura, Curtis C. Ling, and Kishore V. Seendripu on September 25, 2003 and is headquartered in Carlsbad, CA.

MaxLinear Inc

MaxLinear is currently trending as investors weigh strong infrastructure-driven earnings and upward guidance against significant volatility and skepticism regarding the sustainability of its rapid price rally. Community discourse is sharply divided, with some traders focused on potential short-squeeze dynamics and the company's role in AI data center growth, while others express concerns over valuation, lack of profitability, and the risk of a sharp correction.

Index Coop is a decentralized autonomous organization (DAO) that builds structured DeFi products and strategy tokens. Index Coop offers a suite of sector index products, leverage and inverse products, and yield-generating products. The product suite runs on Set Protocol, an audited, self-custodial DeFi tool that allows for the creation and management of Ethereum-based (or ERC-20) tokens. Changes to the DAO are voted on by the owners of a governance token called INDEX and then implemented by a team of developers. INDEX holders wield voting power on a 1:1 basis, meaning one token equals one vote.

Index Cooperative

Index Cooperative is generating community buzz driven by its low circulating supply and potential as a DeFi infrastructure play, with investors actively discussing speculative price targets. While some participants express frustration over low volume and delisting concerns on certain exchanges, others are framing it as a "sleeping giant" primed for a breakout during the next altcoin cycle.

Atomera, Inc. engages in the development, commercialization, and licensing of proprietary processes and technologies for the semiconductor industry. It developed Mears Silicon Technology, which increases performance and power efficiency in semiconductor transistors. The company was founded by Robert Mears on November 26, 2001 and is headquartered in Los Gatos, CA.

Atomera Inc

Atomera is trending as investors aggressively trade around significant volume and high short interest, with the community actively speculating that an imminent commercial deal or partnership news is on the horizon. Despite persistent skepticism regarding the lack of recurring revenue, sentiment is currently buoyed by hopeful 'dot-connecting' related to the firm's advanced semiconductor material integration and anticipated industry collaborations.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is trending as investors await a critical Phase 3 data readout for its hereditary angioedema therapy, with high short interest fueling anticipation for a potential short squeeze. The community is actively discussing the stock's significant price volatility and the potential impact of this binary event on the company's long-term position in the gene-editing sector.

Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. Its platform includes common light chain-focused antibody discovery, human display for antibody tuning, stitchmabs, and highly modular and manufacturable bispecific candidates. The company was founded by Thomas J. Schuetz in 2014 and is headquartered in Boston, MA.

Compass Therapeutics Inc

Compass Therapeutics is currently trending as investors focus on the upcoming topline secondary endpoint data from its COMPANION-002 Phase 2/3 study, which is a critical binary event for the company's lead asset in the biliary tract cancer space. Community sentiment remains highly active with discussions centered on potential stock price catalysts and technical indicators, though some market participants are expressing caution regarding clinical trial uncertainties and the speculative nature of biotech momentum plays.

Harvest Portfolios Group Inc - Harvest Canadian High Income Shares ETF

Harvest Canadian High Income Shares ETF

Investors are closely monitoring Harvest Canadian High Income Shares due to recent distribution adjustments and content creator analysis highlighting the fund's role in passive income strategies. Discussions across social platforms center on the portfolio's stability and its competitive positioning within the broader Canadian covered call ETF sector.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

The iShares Semiconductor ETF (SOXX) is currently at the center of a heated debate as traders weigh its historic multi-week winning streak against warnings from researchers that the sector has become dangerously overextended. Community sentiment is deeply divided between those betting on an inevitable, sharp mean reversion and investors who view the rally as a sign of continued dominance in AI-driven infrastructure.

"KISHU INU was created in April 2021 with the goal of being a decentralized meme project with true purpose.  KISHU’s mission is to bring popular cryptocurrency concepts to the mainstream. Unlike older, comparable projects, KISHU introduces holders to next-gen concepts such as participation rewards, NFTs, decentralized exchanges, and more.  Within the first month of its launch, KISHU made history by surpassing a $2 billion market cap and over 100,000 holders. This was an unprecedented milestone for a project of its kind, and proved the world’s belief in the project."

KISHU INU

KISHU INU is trending as retail investors speculate on a potential rally, driven by long-term holders debating the coin's utility, burn mechanisms, and comparisons to previous meme coin market cycles. The community remains polarized, with some accumulating positions in anticipation of a new market cycle, while others warn of its historical performance and ongoing liquidity concerns.

Amkor Technology, Inc. engages in the provision of outsourced semiconductor packaging and test services. Its services include design, package characterization, test, and wafer bumping services. The company was founded in 1968 and is headquartered in Tempe, AZ.

AMKOR Technology Inc.

Amkor Technology is trending as market participants closely monitor the stock ahead of its upcoming earnings report, with community sentiment fueled by its strategic position as a key advanced packaging provider for major AI hardware players. Traders are actively debating the stock's volatility and its long-term growth prospects as investors pivot toward semiconductor 'pick-and-shovel' plays that support expanding data center and high-performance computing infrastructure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of InspireMD, Inc. (NASDAQ: NSPR)

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of InspireMD, Inc. (NASDAQ: NSPR) SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of...

After Plunging 15.2% in 4 Weeks, Here's Why the Trend Might Reverse for InspireMD (NSPR)

InspireMD (NSPR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

InspireMD (NYSE:NSPR) Trading Down 6.7% - What's Next?

InspireMD (NYSE:NSPR) Shares Down 6.7% - Time to Sell...

InspireMD, Inc. (NSPR) Reports Q4 Loss, Beats Revenue Estimates

InspireMD (NSPR) delivered earnings and revenue surprises of +36.36% and +14.93%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

921,587 Shares in InspireMD, Inc. $NSPR Purchased by Ghisallo Capital Management LLC

Ghisallo Capital Management LLC purchased a new position in InspireMD, Inc. (NYSE:NSPR - Free Report) during the 3rd quarter, according to its most recent filing with the Securities & Exchange...

Rosalind Advisors Inc. Purchases 1,616,644 Shares of InspireMD, Inc. $NSPR

Rosalind Advisors Inc. lifted its position in InspireMD, Inc. (NYSE:NSPR - Free Report) by 70.6% during the third quarter, according to the company in its most recent filing with the Securities...

Stereotaxis Inc. (STXS) Reports Q4 Loss, Lags Revenue Estimates

Stereotaxis (STXS) delivered earnings and revenue surprises of +5.21% and -5.55%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

NeuroPace, Inc. (NPCE) Reports Q4 Loss, Beats Revenue Estimates

NeuroPace (NPCE) delivered earnings and revenue surprises of +41.48% and +2.47%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Penumbra (PEN) Surpasses Q4 Earnings and Revenue Estimates

Penumbra (PEN) delivered earnings and revenue surprises of +5.36% and +6.74%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Aberdeen Group plc Makes New Investment in InspireMD, Inc. $NSPR

Aberdeen Group plc bought a new stake in shares of InspireMD, Inc. (NYSE:NSPR - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange...

InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Miami, FL.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.18	--	--	N/A
Q4 '25	-$0.19	-$0.14	27.59%	BEAT
Q3 '25	-$0.19	-$0.17	12.82%	BEAT
Q2 '25	-$0.26	-$0.26	--	EXPECTED
Q1 '25	-$0.20	-$0.22	-10.00%	MISSED

NSPR
InspireMD Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest NSPR News

NSPRInspireMD Inc